NeueHealth (NEUE) & The Competition Head to Head Comparison

NeueHealth (NYSE:NEUE) is one of 14 publicly-traded companies in the “Hospital & medical service plans” industry, but how does it weigh in compared to its competitors? We will compare NeueHealth to similar businesses based on the strength of its institutional ownership, valuation, analyst recommendations, risk, profitability, earnings and dividends.

Earnings and Valuation

This table compares NeueHealth and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NeueHealth	$1.16 billion	-$1.15 billion	-0.04
NeueHealth Competitors	$80.60 billion	$2.78 billion	8.68

NeueHealth’s competitors have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares NeueHealth and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
NeueHealth Competitors	0.04%	-1.59%	-0.04%

Risk and Volatility

NeueHealth has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, NeueHealth’s competitors have a beta of 0.95, suggesting that their average stock price is 5% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and target prices for NeueHealth and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
NeueHealth Competitors	94	1116	2552	98	2.69

NeueHealth presently has a consensus target price of $8.00, indicating a potential upside of 31.80%. As a group, “Hospital & medical service plans” companies have a potential upside of 20.47%. Given NeueHealth’s higher probable upside, research analysts plainly believe NeueHealth is more favorable than its competitors.

Institutional and Insider Ownership

63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are owned by institutional investors. 64.3% of NeueHealth shares are owned by insiders. Comparatively, 10.3% of shares of all “Hospital & medical service plans” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

NeueHealth competitors beat NeueHealth on 10 of the 13 factors compared.

About NeueHealth

NeueHealth, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, Bright HealthCare and Consumer Care. The Consumer Care segment delivers virtual and in-person clinical care services contracts through primary care clinics. It operates managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers medicare health plan products to consumers. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.